These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8615863)

  • 21. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
    Bournique B; Lambert N; Boukaiba R; Martinet M
    Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives.
    Shou M; Mei Q; Ettore MW; Dai R; Baillie TA; Rushmore TH
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):845-53. PubMed ID: 10359672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism.
    Shou M; Lu T; Krausz KW; Sai Y; Yang T; Korzekwa KR; Gonzalez FJ; Gelboin HV
    Eur J Pharmacol; 2000 Apr; 394(2-3):199-209. PubMed ID: 10771285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
    Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cDNA-expressed human cytochromes P450 in the metabolism of diazepam.
    Yang TJ; Shou M; Korzekwa KR; Gonzalez FJ; Gelboin HV; Yang SK
    Biochem Pharmacol; 1998 Mar; 55(6):889-96. PubMed ID: 9586962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?
    Kharasch ED; Thummel KE
    Anesth Analg; 1993 May; 76(5):1033-9. PubMed ID: 8484504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.
    Rahman A; Korzekwa KR; Grogan J; Gonzalez FJ; Harris JW
    Cancer Res; 1994 Nov; 54(21):5543-6. PubMed ID: 7923194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
    Brandes LJ; Queen GM; LaBella FS
    Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
    Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
    Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil.
    Tracy TS; Korzekwa KR; Gonzalez FJ; Wainer IW
    Br J Clin Pharmacol; 1999 May; 47(5):545-52. PubMed ID: 10336579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.
    Shou M; Krausz KW; Gonzalez FJ; Gelboin HV
    Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
    Teiber JF; Hollenberg PF
    Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.
    Iribarne C; Dréano Y; Bardou LG; Ménez JF; Berthou F
    Toxicology; 1997 Feb; 117(1):13-23. PubMed ID: 9020195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactivity of thirteen monoclonal antibodies with ten vaccinia cDNA expressed rat, mouse and human cytochrome P450s.
    Goldfarb I; Korzekwa K; Krausz KW; Gonzalez F; Gelboin HV
    Biochem Pharmacol; 1993 Sep; 46(5):787-90. PubMed ID: 8373431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
    Yamazaki H; Shaw PM; Guengerich FP; Shimada T
    Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase.
    Satoh T; Fujita KI; Munakata H; Itoh S; Nakamura K; Kamataki T; Itoh S; Yoshizawa I
    Anal Biochem; 2000 Nov; 286(2):179-86. PubMed ID: 11067738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory anti-peptide antibody against human CYP3A4.
    Wang RW; Lu AY
    Drug Metab Dispos; 1997 Jun; 25(6):762-7. PubMed ID: 9193880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9.
    Kent UM; Aviram M; Rosenblat M; Hollenberg PF
    Drug Metab Dispos; 2002 Jun; 30(6):709-15. PubMed ID: 12019199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.